These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 12065066)
1. Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation. Burls A; Clark W; Stewart T; Preston C; Bryan S; Jefferson T; Fry-Smith A Health Technol Assess; 2002; 6(9):1-87. PubMed ID: 12065066 [No Abstract] [Full Text] [Related]
2. [New flu therapy. Progress or burden for the budget?]. Vogel GE MMW Fortschr Med; 2000 Feb; 142(8):14. PubMed ID: 10810861 [No Abstract] [Full Text] [Related]
3. Summaries for patients. Influenza vaccination or antiviral treatment for healthy working adults: an economic analysis. Ann Intern Med; 2002 Aug; 137(4):I22. PubMed ID: 12186536 [No Abstract] [Full Text] [Related]
4. What is the best antiviral agent for influenza infection? Fagan HB; Moeller AH Am Fam Physician; 2004 Oct; 70(7):1331-2. PubMed ID: 15508545 [No Abstract] [Full Text] [Related]
6. Economic analysis of influenza vaccination and antiviral treatment for healthy working adults. Lee PY; Matchar DB; Clements DA; Huber J; Hamilton JD; Peterson ED Ann Intern Med; 2002 Aug; 137(4):225-31. PubMed ID: 12186512 [TBL] [Abstract][Full Text] [Related]
7. NICE advises against prescribing zanamivir until further evidence emerges. Commun Dis Rep CDR Wkly; 1999 Oct; 9(42):371. PubMed ID: 10582390 [No Abstract] [Full Text] [Related]
8. Summaries for patients. Cost-effective management of flu in adults older than 65 years of age. Ann Intern Med; 2003 Sep; 139(5 Pt 1):I27. PubMed ID: 12965955 [No Abstract] [Full Text] [Related]
9. Bedside rapid flu test and zanamivir prescription in healthy working adults: a cost-benefit analysis. Schwarzinger M; Housset B; Carrat F Pharmacoeconomics; 2003; 21(3):215-24. PubMed ID: 12558471 [TBL] [Abstract][Full Text] [Related]
10. Clinical effectiveness and cost effectiveness of zanamivir (Relenza): translating the evidence into clinical practice, a National Institute for Clinical Excellence view. Barnett D Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1899-903. PubMed ID: 11779390 [TBL] [Abstract][Full Text] [Related]
12. Evidence-based emergency medicine/systematic review abstract. Use of the neuraminidase inhibitor class of antiviral drugs for treatment of healthy adults with an acute influenza-like illness. Pitts SR Ann Emerg Med; 2002 May; 39(5):552-4. PubMed ID: 11973564 [No Abstract] [Full Text] [Related]
13. Zanamivir: an update of its use in influenza. Cheer SM; Wagstaff AJ Drugs; 2002; 62(1):71-106. PubMed ID: 11790157 [TBL] [Abstract][Full Text] [Related]
14. Zanamivir for influenza: a public health perspective. Its use will require careful management by GPs. Nguyen-Van-Tam JS BMJ; 1999 Sep; 319(7211):655-6. PubMed ID: 10480805 [No Abstract] [Full Text] [Related]
15. Influenza and the new antivirals: potential for misdiagnosis and possible misuse of antivirals. Lim S; Richardson D; Conly JM Can Commun Dis Rep; 2000 Dec; 26(23):202-5. PubMed ID: 11131689 [No Abstract] [Full Text] [Related]
16. Influenza treatment with neuraminidase inhibitors: cost-effectiveness and cost-utility in healthy adults in the United Kingdom. Sander B; Gyldmark M; Hayden FG; Morris J; Mueller E; Bergemann R Eur J Health Econ; 2005 Sep; 6(3):244-52. PubMed ID: 15875227 [TBL] [Abstract][Full Text] [Related]
17. Zanamivir, influenza, and meningococcal disease. NHS regulations are of questionable legality. Thomas PD BMJ; 2000 Feb; 320(7231):378. PubMed ID: 10712027 [No Abstract] [Full Text] [Related]
18. Unprepared for an influenza pandemic. Tooley P Lancet; 2001 Aug; 358(9282):670-1. PubMed ID: 11545086 [No Abstract] [Full Text] [Related]
19. Study allays therapy concern, finds new flu drug safe for patients with asthma, COPD. Stephenson J JAMA; 2000 Dec; 284(24):3115-6. PubMed ID: 11135756 [No Abstract] [Full Text] [Related]
20. The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation. Johny AA; Clark A; Price N; Carrington D; Oakhill A; Marks DI Bone Marrow Transplant; 2002 Jan; 29(2):113-5. PubMed ID: 11850704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]